Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study
- PMID: 34165816
- DOI: 10.1002/ajh.26280
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
